About
Abingdon Health plc is an international developer, manufacturer, and distributor of lateral flow assay diagnostic tests, commonly known as rapid tests. Founded in 2008 and headquartered in York, England, with additional locations in Doncaster and Madison, USA, the company specializes in comprehensive service solutions for lateral flow diagnostics, guiding projects from initial concept to commercial success. As both a Contract Research Organisation (CRO) and a Contract Development & Manufacturing Organisation (CDMO), Abingdon Health offers a wide range of services, including product development, regulatory support, technology transfer, and large-scale manufacturing. The company serves various industries, such as healthcare, infectious disease, clinical testing, animal health, and environmental testing. Notable products include the AbC-19 Rapid Test for COVID-19 and the AppDx® smartphone reader. Abingdon Health also markets the Abingdon Simply Test range, providing self-tests directly to consumers through e-commerce and pharmacy chains. Their mission is to enhance access to rapid diagnostic results globally, improving health outcomes through innovative testing solutions.
Technologies
Keywords
Company Information
-
Employees 120
-
Founded 2008
-
Annual Revenue $7762000
-
Total Funding $57759253
Location
Sand Hutton, England, United Kingdom, YO41 1LZ